# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001401914-25-000016
Filing Date
2025-04-24
Accepted
2025-04-24 16:32:42
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | defa14a2024additionalmater.htm | DEFA14A | 12348
2 |  | darebioscienceinc_vxnaxp31b.jpg | GRAPHIC | 525907
3 |  | darebioscienceinc_vxnaxp31c.jpg | GRAPHIC | 390450
| Complete submission text file | 0001401914-25-000016.txt |  | 1275214

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 25867841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)